LON:OPTI OptiBiotix Health (OPTI) Share Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free OPTI Stock Alerts GBX 17.69 -0.06 (-0.34%) (As of 04:05 PM ET) Add Compare Share Share Today's Range 17.50▼ 1850-Day Range 17.75▼ 2852-Week Range 5.57▼ 43.50Volume16,701 shsAverage Volume234,707 shsMarket Capitalization£16.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get OptiBiotix Health alerts: Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About OptiBiotix Health Stock (LON:OPTI)OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.Read More OPTI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPTI Stock News HeadlinesApril 24, 2024 | forbes.com5 Best Stair Lifts Of 2024April 3, 2024 | forbes.comBest Protein Powders Of 2024, According To ExpertsApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.March 26, 2024 | lse.co.ukOptiBiotix Health raises GBP1.4 million to invest in "driving sales"February 28, 2024 | msn.comYork's OptiBiotix Health grows sales as it eyes US and Asia opportunitiesFebruary 27, 2024 | forbes.comBest CBD Gummies For Sleep Of 2024January 22, 2024 | lse.co.ukOptiBiotix Health Share ChatJanuary 18, 2024 | forbes.comBest Pre-Workouts Of 2024, According To ExpertsApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.December 19, 2023 | morningstar.comOptiBiotix Health PLC OPTINovember 28, 2023 | lse.co.ukTRADING UPDATES: Scancell trial progresses; OptiBiotix inks new dealNovember 1, 2023 | lse.co.ukOptiBiotix says market still "volatile" but partner sales improvingOctober 23, 2023 | marketwatch.comOptiBiotix Health Agrees With Tata Chemicals to Use Fossence IngredientSeptember 20, 2023 | forbes.comAetna Medicare Advantage Review (2023)September 8, 2023 | uk.news.yahoo.comYork Bio-tech firm reports record online salesAugust 29, 2023 | msn.comOptiBiotix Health achieved its highest ever own brand online sales in JulyJune 29, 2023 | finance.yahoo.comOptiBiotix Health Full Year 2022 Earnings: EPS: UK£0.029 (vs UK£0.071 in FY 2021)May 17, 2023 | forbes.comWhat Is The Mediterranean Diet? Benefits, Risks And MoreApril 29, 2023 | marketwatch.comHome Meal Replacement (HMR) Market | Report By 2023-2030February 23, 2023 | lse.co.ukOptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiaryFebruary 18, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Global Industry Share, Key Dynamics and Forecast to 2028January 15, 2023 | marketwatch.comHome Meal Replacement (HMR) Market 2023 : Industry Analysis, Opportunities, Technology, Top Players and Growth Forecast 2028December 5, 2022 | marketwatch.comOptiBiotix Health Shares Fall on Discounted Fund RaisingOctober 24, 2022 | lse.co.ukOptiBiotix Health gets approval to sell products in Saudi ArabiaAugust 30, 2022 | nz.finance.yahoo.comPrebiotic Ingredients Market Size to Reach Around USD 20.78 Bn by 2030August 24, 2022 | lse.co.ukOptiBiotix shares plunge on "very difficult trading" in half-yearAugust 24, 2022 | marketwatch.comOptiBiotix Health Sees 1H Sales Below Expectations; Shares DiveSee More Headlines Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/24/2020Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OPTI Previous SymbolLON:CMI CUSIPN/A CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-13,180,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-85.52% Return on Assets-8.50% Debt Debt-to-Equity Ratio4.51 Current Ratio3.59 Quick Ratio7.89 Sales & Book Value Annual Sales£1.26 million Price / Sales12.80 Cash FlowGBX 2.04 per share Price / Cash Flow8.68 Book ValueGBX 10 per share Price / Book1.77Miscellaneous Outstanding Shares91,190,000Free FloatN/AMarket Cap£16.13 million OptionableNot Optionable Beta1.62 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Stephen Patrick O'Hara (Age 64)Founder, CEO & Executive Director Comp: $151kDr. Sofia Kolyda (Age 51)Executive Director of Research & Development and Executive Director Comp: $88kMr. Mark Kingsley Collingbourne (Age 58)CFO & Secretary Paul CanningsHead of Operations & QualityKevin James NewmanCorporate Development DirectorMr. Karl BurkittMarketing DirectorMore ExecutivesKey CompetitorsOndine BiomedicalLON:OBIOxford BioDynamicsLON:OBDNetScientificLON:NSCISkinBioTherapeuticsLON:SBTXOncimmuneLON:ONCView All Competitors OPTI Stock Analysis - Frequently Asked Questions How have OPTI shares performed in 2024? OptiBiotix Health's stock was trading at GBX 26.75 at the beginning of the year. Since then, OPTI stock has decreased by 33.9% and is now trading at GBX 17.69. View the best growth stocks for 2024 here. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) posted its earnings results on Thursday, September, 24th. The company reported ($0.70) EPS for the quarter. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include Digital Globe Services (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO). How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OPTI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
